All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • Market intelligence reports
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, December 12, 2019
Home » Topics » Newco news

Newco news
%{topic} RSS Feed RSS

AI-tech-head.png

Rad AI debuts with $4M to help fight issues in radiology

November 25, 2019
By Liz Hollis
No Comments
Radiologist burnout is a common problem. To combat this issue, Berkeley, Calif.-based Rad AI has launched with a $4 million seed round led by Gradient Ventures, Google's AI-focused venture fund. Other participants in the round were UP2398, Precursor Ventures, GMO Venture Partners, Array Ventures, Hike Ventures, Fifty Years VC and various angels.
Read More
Lea-Hachigian,-co-founder,-director-and-president,-Immunitas-Therapeutics-11-22-hero
Newco news

Human nature: Single-cell genomics Immunitas launches with a series A

November 22, 2019
By Lee Landenberger
No Comments
The research challenge facing the scientific founders of newly launched Immunitas Therapeutics Inc. was getting human samples to deeply analyze in their quest to understand autoimmunity. While the research continued slowly, the science raced ahead. 
Read More
Opsens-OptoWire-11-22.png

Opsens expands core technology into growing structural cardiology space

November 22, 2019
By David Godkin
No Comments
TORONTO – If you’ve successfully expanded your medical technologies business once, why not do it a second time? The answer was quick in coming Nov. 5, when Quebec City-based Opsens Inc. announced its next goal: To accelerate development of products beyond its current line of technologies for measuring coronary pressure into the structural cardiology space.
Read More
seoul korea
Newco news

SL Bigen secures ₩3B from Yuhan for CAR-NK therapy

November 19, 2019
By Jihyun Kim
No Comments
HONG KONG – South Korean pharmaceutical giant Yuhan Corp. has invested ₩3 billion (US$2.6 million) in SL Bigen Co. Ltd., a Korean biotech based in Seongnam, Gyeonggi-do, that is focused on chimeric antigen receptor-directed natural killer (CAR-NK) therapy.
Read More
Newco news

SL Bigen secures ₩3B from Yuhan for CAR-NK therapy

November 19, 2019
By Jihyun Kim
No Comments
HONG KONG – South Korean pharmaceutical giant Yuhan Corp. has invested ₩3 billion (US$2.6 million) in SL Bigen Co. Ltd., a Korean biotech based in Seongnam, Gyeonggi-do, that is focused on chimeric antigen receptor-directed natural killer (CAR-NK) therapy.
Read More
Scanwell-UTI-test-11-15.jpg

Scanwell Health aims to ease testing for UTIs with smartphone-enabled option

November 15, 2019
By Liz Hollis
No Comments
Urinary tract infections (UTIs) are a common reason for women to visit their doctor. While virtual doctor visits have been possible to detect UTIs, patient-reported symptoms typically have drove diagnoses. Now, Los Angeles-based Scanwell Health is bringing its at-home smartphone-enabled test and treatment service for UTIs to all 50 states. Scanwell said its offering its the first U.S. FDA-cleared urine testing app available over-the-counter without a prescription.
Read More

Hemoalgae looking to disrupt the health care space with new coagulation solution

November 15, 2019
By Sergio Held
No Comments
Hemoalgae, from Cartago, Costa Rica, is moving forward with the extraction and development of molecules of hirudin, a peptide with anticoagulant properties, which impacts the biotech and med-tech sectors. Their uniqueness? Sourcing the anticoagulant hirudin from algae.
Read More
Costa-Rica-flag

Costa Rican biotech startup looking to disrupt with a coagulation solution

November 15, 2019
By Sergio Held
No Comments
SAN JOSE, Costa Rica – Hemoalgae, from Cartago, Costa Rica, is moving forward with the extraction and development of molecules of hirudin, a peptide with anticoagulant properties, which impacts the biotech and med-tech sectors.
Read More

NIH-backed Medicasafe aims for FDA clearance of opioid use disorder drug-device combo

November 13, 2019
By Stacy Lawrence
No Comments
Drug addiction has often proven resistant to the best efforts for treatment. New York-based startup Medicasafe Inc. hopes to provide another tool in the arsenal to boost opioid use disorder (OUD) treatment. Rather than send a recovering addict home every couple of weeks with an unmonitored and uncontrolled supply of buprenorphine and naloxone, it has developed a drug-device combination product that digitally enables and tracks patient retrieval of these drugs.
Read More
Alan-Trounson,-Cartherics-11-11

Australia's Cartherics creates next generation CAR T therapies

November 10, 2019
By Tamra Sami
No Comments
PERTH, Australia – Melbourne-based Cartherics Pty Ltd. plans on taking its pluripotent stem cell technology into the clinic next year. It is employing advanced gene editing techniques for the next generation of CAR T therapy.
Read More
Previous 1 2 3 4 5 6 Next

Popular Stories

  • Bioworld MedTech’s Oncology Extra

    BioWorld MedTech
    Keeping you up to date on recent developments in oncology.
  • Ear-disorders

    FDA gives thumbs up to Cochlear’s implantable bone conduction hearing system

    BioWorld MedTech
    The U.S. FDA has cleared Cochlear Ltd.’s newest cochlear implant, the Osia 2 system, an active implantable bone conduction hearing system. Unlike Cochlear’s...
  • Drugs-pills-global-map-

    Analysis by U.K. startup Medbelle highlights extent of drug pricing disparity

    BioWorld
    LONDON – It’s no secret that American citizens pay the most for drugs, but the extent of the disparity is laid bare in a new index of the prices of 13 medicines...
  • Frankyoung-11-27

    Buoyed by optimism and love of family, former FDA chief Frank Young leaned into storms

    BioWorld
    Commissioner of the FDA for five years starting in 1984, Frank Young relished his position “at the vortex of controversy” as he sought to deal with the AIDS...
  • Biopharma companies continue their strong momentum in November

    BioWorld
    After being in the doldrums for the majority of the year, public biopharmaceutical companies, it appears, have turned the corner and are now on a major upswing.
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Archives
    • Contact us
    • Cookie policy
    • Copyright notice
    • Privacy policy
    • Share your news
    • Staff
    • Terms of use
Follow Us

Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing